2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
On September 14, 2022, William Gradishar, MD moderated a virtual workshop with fellow oncologists to discuss best practices for biomarker testing, the emerging concept of HER2-low BC, and treatment approaches for BC throughout the course of the disease. This article summarizes key takeaways and stakeholder insights from this workshop.